George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
There was an outbreak at a factory I work with where they have been testing all the contractors coming onto site with lfts. They tested two of the guys who tested positive with it and the lft gave them the all clear. I think the lft’s are dangerous. They’re impossible to do properly on yourself and a bad result potentially spreads it further. They put everyone at higher risk but the company and the government are just ticking a health and safety box. Annoys the hell out of me. There needs to be better guidance otherwise it just becomes a total waste of money and time.
Pretty happy with today’s action. It confirms there are not that many sellers left. A pretty meagre drop on news that if true should have been devastating. Those that would have sold have sold and the sooner they are all out the sooner we can break upwards for all time highs.
Just that the market usually values based on future earnings.... if you are an optimist you see the cash, the potential for non Covid profits, the acquisitions. If your a pessimist you don’t. Current valuation is just looking at the cash they are expected to accumulate over the next 2-3 years. (Circa £400 million) Hence why optimists are excited as they think we’ll do something with that cash and the pe can expand to 10-20 as it does.
If you double down perhaps you can lower your target? Doing nothing and just taking a loss is never a good strategy.... if it’s a loss making company that’s popped get out.... if there is future value not being realised double down when given the opportunity. Then at £10 you can decide whether it’s time to take some of the table or if the story has evolved too a higher target.
To be fair the company has had a meteoric rise... I have been in it since £1.70.... approximately a year of holding, does that make me a long term holder? Not really. It seems to me some have invested here with very short term views and then are annoyed at the price after a month. The company is still on a 380% gain in a year. And now it’s incredibly undervalued. I think management can be proud of their achievements for shareholders so far and those who hold will be rewarded in time. I can’t imagine management are too worried about the current price as they are busy building the platform for future growth and the only investors who deem they have lost out are the ones with very short term views who are looking to make a quick buck. Take a longer term view and don’t worry about it. That’s what the likes of black rock are doing. Even Amazon had 90% drops on the way up. If you had stuck a £1000 in that back at the start you’d be a millionaire now
Interesting, it mentions 50 million patients currently in the RNS. Up on 10 million previously so sounds like complications with Covid are producing other illnesses that need testing for.... aspergillosis is treatable unlike Covid. So for anyone on a ventilator or indeed who doesn’t have Covid but is immunocomprimised should possibly be tested for it. We’re beginning to see how Novacyt can leverage their newfound position to become a world leader in diagnostics.... even 10% of that market is worth £50 million
There are some subtle clues in here in absence of sales figures. Promate has obviously been rolled out and found very successful... so much that they are going to expand to two gene.... presumably a big market here that would want this or why bother.
Saliva testing- game changer... we know the current nose swabs are not comfortable and combined with lft make our mass testing pretty pointless as you can’t test yourself properly. particularly on asymptomatic individuals who think they don’t have it anyway. Saliva testing by pcr even if slightly less accurate would be far better.
Look at the areas they are investing in R and D and this tells you what’s being successful and what is likely to have provided fruit.
Truly pointless giving people LFT’s to test themselves. It is not a nice procedure and most people or children aren’t sadists so they are going to do it wrong and we’ll get a high number of false negatives. A waste of money AND more people will needlessly die.
Interesting - no news is good news then. They can only talk about it if there isn’t a contract anymore...and the contract may run for 6 months sept-March before the need to carry out the official phase 1 extension
The IG thing is irrelevant. The fundamentals don’t change... so if someone sells it just looks even better value and someone else will buy their shares. It’s only relevant if you your a day trader and the small percentages matter too you.
Yep lots of them about at the moment.... don’t sell your shares!! If they announce we’re aren’t getting an extension then fair enough. The fundamentals haven’t changed we’re just going through a no news period and the market has been taking advantage of it. GM hasn’t sold, black rock and many other funds have accumulated. Seriously undervalued. IMHO
Stinks of bottom dwellers either shorting the stock or looking for an entry.. we’re very close to contract renewal and announcements, potentially of phase 2. Having held all the way down from £12. Now is not the time to panic sell!!
Hi I’ve picked SDI as a possible company that I’d like to invest in. It’s got a great history of growing revenue, profit, earnings without need to dilute shareholders and I can see the recent trading updates suggest growth is to continue through 21/22. I wonder if any long term holders can explain whether the share has more broader appeal beyond 2022?
Way I see it PCR testing will be used in healthcare settings for years to come. LFT useful for mass testing, but this has a shorter shelf life.... as the counts drop and we open back up the need for mass testing (lft testing ) will reduce. However healthcare settings will need to distinguish between flu, coronavirus, variants for the foreseeable future.... we need a diagnostic network that can do this as well as quickly pick up future variants or new diseases.
Pillar 1 pcr testing still growing, now 200,000 tests a day. We will get our extension as we are a central part of delivering this service to the NHS. It’s not clear to me when the contract was to end either I was thinking mid to late February, but it is clear that at the current run rates that the nhs probably have stocks well into March. Promate has been developed for and validated by the nhs so no doubt this will be included in the extension.
We could see news anytime now so it’s very risky to sell after holding through the majority of the decline.... if you had been sat on the sidelines it would be now that you’d be considering buying in.
Yeah it’s not going to magically change the trend of moving too online shopping. Why do we buy online? It’s not about cost, it’s about convenience. Most traditional shops are also trying to move to/ incorporate online models as they have realised this. So an online tax will hit them too. Ultimately it will just accelerate the demise of the high street